- Home
- ORIC vs SDHC Comparison
ORIC vs SDHC Comparison
Compare ORIC & SDHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- SDHC
- Stock Information
- Founded
- ORIC 2014
- SDHC 2008
- Country
- ORIC United States
- SDHC United States
- Employees
- ORIC N/A
- SDHC N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- SDHC
- Sector
- ORIC Health Care
- SDHC
- Exchange
- ORIC Nasdaq
- SDHC Nasdaq
- Market Cap
- ORIC 974.1M
- SDHC 933.4M
- IPO Year
- ORIC 2020
- SDHC 2024
- Fundamental
- Price
- ORIC $10.88
- SDHC $21.00
- Analyst Decision
- ORIC Strong Buy
- SDHC Hold
- Analyst Count
- ORIC 10
- SDHC 4
- Target Price
- ORIC $17.33
- SDHC $23.63
- AVG Volume (30 Days)
- ORIC 782.2K
- SDHC 66.3K
- Earning Date
- ORIC 08-12-2025
- SDHC 08-06-2025
- Dividend Yield
- ORIC N/A
- SDHC N/A
- EPS Growth
- ORIC N/A
- SDHC N/A
- EPS
- ORIC N/A
- SDHC N/A
- Revenue
- ORIC N/A
- SDHC $1,013,967,000.00
- Revenue This Year
- ORIC N/A
- SDHC $1.50
- Revenue Next Year
- ORIC N/A
- SDHC $9.38
- P/E Ratio
- ORIC N/A
- SDHC $74.50
- Revenue Growth
- ORIC N/A
- SDHC 22.89
- 52 Week Low
- ORIC $3.90
- SDHC $16.28
- 52 Week High
- ORIC $14.67
- SDHC $39.50
- Technical
- Relative Strength Index (RSI)
- ORIC 63.04
- SDHC 57.17
- Support Level
- ORIC $9.87
- SDHC $18.42
- Resistance Level
- ORIC $10.35
- SDHC $20.67
- Average True Range (ATR)
- ORIC 0.44
- SDHC 1.01
- MACD
- ORIC 0.14
- SDHC 0.01
- Stochastic Oscillator
- ORIC 79.99
- SDHC 98.85
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About SDHC Smith Douglas Homes Corp.
Smith Douglas Homes Corp is a company engaged in the design, construction, and sale of single-family homes in some of the highest growth and desirable markets in the Southeastern United States. It is organized into eight geographical divisions which comprise two reportable segments. Its Southeast segment consists of Atlanta, Central Georgia, Charlotte, Greenville, and Raleigh divisions. Its Central segment consists of Alabama, Houston, and Nashville divisions.